Preterm Birth – Intervention & Prevention
Role of Cervical Ultrasound and Vaginal Progesterone

Registration Statement

By clicking the Registration Button below you are agreeing that you have read and understood the CME Statements below.


View Agenda  Colorado Convention CenterDenverCO Sunday
Jun 26, 2011 11:00 AM


  Venue City State Date  
View Agenda  Colorado Convention Center      Denver CO    Sunday, June 26, 2011 11:00AM To register scroll down.

Program Description

Preterm birth (PTB) – birth at <37 completed weeks of gestation – occurs in approximately 13% of pregnancies and is a major public health problem in the US. Preterm neonates are at greater risk for morbidity and mortality than infants born at term, as a variety of health and developmental complications can arise, including acute respiratory distress syndrome, central nervous system deficits, vision impairments, gastrointestinal problems, and long-term motor and cognitive disabilities. PTB also has considerable emotional and economic impacts on families and causes a significant burden to the health care system.

Significant improvements have been made in treating preterm infants and improving survival. Additional effort should be aimed at reducing the incidence of PTB by focusing on better identification of women at risk for PTB and initiation of effective prevention strategies for women at risk. Effective obstetric nurse care and interventions in these two key areas can help promote maternal-fetal well-being, minimize risk, and enhance patient safety.


JANINE BIEDA, PhD, MS, CNM, BSN, RN (Program Chair)

Perinatology Research Branch/NICHD/NIH/DHHS

Center for Advanced Obstetrical Care and Research

Detroit, MI


Professor and Associate Chairman,

Department of Obstetrics and Gynecology

Wayne State University School of Medicine

Director of Obstetric Ultrasound Center for

Fetal Diagnosis and Therapy

Hutzel Women’s Hospital
Detroit, MI

Target Audience

This activity is intended for nursing professions involved in the recognition and management of women at risk for PTB

Educational Objectives

This program is designed to address the following IOM competencies: provide patient-centered care and employ evidence-based practice.

At the conclusion of this activity, participants should be able to:

  • Explain the clinical burden of PTB and the role of the nurse in PTB management

  • Distinguish patients at risk for PTB and initiate screening strategies

  • Explain the data linking the impact of the short cervix with PTB

  • Recognize the need to employ routine transvaginal ultrasonography to measure cervical length in all pregnant patients

  • Assess the risks/benefits of current and emerging interventions


Global Education Group is an approved provider of continuing nursing education by the Colorado Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation

Designation Statement

This educational activity for 1.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

For information about the nursing accreditation of this program, please contact Global at or 303-395-1782.

Disclosure Information

It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty, course directors, program planners/managers and their spouses/life partners have disclosed relevant financial relationships with commercial companies, Global Education Group has processes in place to resolve any conflict of interest. Complete disclosures will be provided to program participants at the beginning of the activity and will be printed in the handouts.


To complete this activity and receive credit, the participant must attend the program, and complete the evaluation form. A CME certificate will be mailed within 6-8 weeks.

There are no fees associated with this program.


Event staff will be glad to assist you with any special needs (e.g. physical, dietary, etc.). Please email at least 5 days prior to the program.

Jointly Sponsored By

This activity is co-provided by:  &

Supported By

Supported by an unrestricted educational grant from Watson Pharmaceuticals, Inc.

Registration Statement

By clicking the Registration Button below you are agreeing that you have read and understood the CME Statements above.

Pre-registration is not required for attendance. Seating is limited and will be provided on a first-come, first serve basis.


View Agenda  Colorado Convention CenterDenverCO Sunday
Jun 26, 2011 11:00 AM